Log in

Relevant bibliographies by topics / Gynecologic malignancy / Journal articles

To see the other types of publications on this topic, follow the link: Gynecologic malignancy.

Journal articles on the topic 'Gynecologic malignancy'

Author: Grafiati

Published: 3 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Gynecologic malignancy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Liwan, Henny, and Steve Hong. "Adnexal Masses in Premenopausal Reproductive Age Women." Current Women s Health Reviews 15, no. 1 (2018): 32–40. http://dx.doi.org/10.2174/1573404813666171016154803.

Full text

Abstract:

Background: Adnexal masses in premenopausal women are common reason for referral to OB-GYN. The etiologies vary from non-gynecologic to gynecologic. Once the mass is determined to be gynecologic in its origin, the gynecologist needs to predict if the mass is more likely to be benign or malignant which could lead to a diagnostic dilemma. Objective: This article reviews different histologic type of ovarian tumors, its epidemiology, clinical presentation, imaging appearance and ovarian tumor markers. Familiarity with these patterns will help the clinician narrow the differential diagnosis thus fa

APA, Harvard, Vancouver, ISO, and other styles

2

Chua, Katherine Jane C., Ricky D. Patel, Radhika Trivedi, et al. "Accuracy in Referrals to Gynecologic Oncologists Based on Clinical Presentation for Ovarian Mass." Diagnostics 10, no. 2 (2020): 106. http://dx.doi.org/10.3390/diagnostics10020106.

Full text

Abstract:

Ovarian cancer is one of the most lethal gynecological cancers in women due to late diagnosis. Despite technological advancements, experienced physicians have high sensitivities and specificities in subjective assessments when combining ultrasound findings and clinical history in analyzing adnexal masses. This study aims to demonstrate general obstetricians and gynecologists’ (OB/GYN) appropriateness in gynecologic oncologist referrals for malignant ovarian masses based on history and physical (H&P), imaging, and available tumor markers. Three board certified OB/GYNs were given 148 cases a

APA, Harvard, Vancouver, ISO, and other styles

3

Ripamonti, Carla, and Eduardo Bruera. "Palliative Management of Malignant Bowel Obstruction." International Journal of Gynecologic Cancer 12, no. 2 (2002): 135–43. http://dx.doi.org/10.1136/ijgc-00009577-200203000-00002.

Full text

Abstract:

Bowel obstruction may be a mode of presentation of intra-abdominal and pelvic malignancy or a feature of recurrent disease following anticancer therapy. Malignant bowel obstruction is well-recognized in gynecologic patients with advanced cancer. Retrospective and autopsy studies found the frequency at approximately 5–51% of patients with gynecological malignancy(1–7). Malignant bowel obstruction (MBO) is particularly frequent in patients with ovarian cancer where it is the most frequent cause of death(7). Patients with stage III and IV ovarian cancer and those with high-grade lesions are at hi

APA, Harvard, Vancouver, ISO, and other styles

4

Ji, Yong Il, and Ki Tae Kim. "Gynecologic malignancy in pregnancy." Obstetrics & Gynecology Science 56, no. 5 (2013): 289. http://dx.doi.org/10.5468/ogs.2013.56.5.289.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Baker, Vicki. "Oncogenes in gynecologic malignancy." Current Opinion in Obstetrics and Gynecology 4, no. 1 (1992): 75???80. http://dx.doi.org/10.1097/00001703-199202000-00011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Makar, Amin P., and Claes G. Tropé. "Gynecologic malignancy and surgery." Current Opinion in Obstetrics and Gynecology 4, no. 3 (1992): 419–29. http://dx.doi.org/10.1097/00001703-199206000-00013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Safer, Umut, Mustafa Kaplan, and Vildan Binay Safer. "Sarcopenia and Gynecologic Malignancy." International Journal of Gynecological Cancer 28, no. 2 (2018): 423. http://dx.doi.org/10.1097/igc.0000000000001177.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Iyer, Revathy. "Imaging of gynecologic malignancy." Seminars in Roentgenology 39, no. 3 (2004): 428–36. http://dx.doi.org/10.1016/j.ro.2004.04.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Bhardwaj, Bikram, Ava Dipan Desai, Bijal Manish Patel, Chetna Deepal Parekh, and Shilpa Mukesh Patel. "Prevalence of hypomagnesemia in patients undergoing gynecological oncology surgery in tertiary care cancer institute of India." International Journal of Reproduction, Contraception, Obstetrics and Gynecology 6, no. 10 (2017): 4355. http://dx.doi.org/10.18203/2320-1770.ijrcog20174404.

Full text

Abstract:

Background: Hypomagnesemia is an important but unknown risk factor for post-operative complications in patients undergoing surgery for presumed gynecological malignancy. This study aims to evaluate the prevalence of hypomagnesemia in patients undergoing surgery for presumed gynecological cancers referred to our tertiary care Cancer Institute.Methods: This is a prospective observational study of 100 patients admitted with provisional diagnosis of malignancy. They underwent surgery in one of the Gynecologic Oncology units at The Gujarat Cancer Research Institute, Ahmedabad from October 2016 to A

APA, Harvard, Vancouver, ISO, and other styles

10

Manegold-Brauer, Gwendolin, Johanna Buechel, Alexandra Knipprath-Mészaros, et al. "Improved Detection Rate of Ovarian Cancer Using a 2-Step Triage Model of the Risk of Malignancy Index and Expert Sonography in an Outpatient Screening Setting." International Journal of Gynecologic Cancer 26, no. 6 (2016): 1062–69. http://dx.doi.org/10.1097/igc.0000000000000718.

Full text

Abstract:

ObjectivePreoperative assessment of adnexal masses with ultrasound has been shown to be time-, cost-effective, and specific. When used in combination with the menopausal status and the tumor marker CA125, the risk of malignancy index (RMI) can be calculated, allowing appropriate preoperative triage of patients to a gynecologist or a gynecological oncologist. Moreover, it allows for accurate planning of the required surgical procedure (laparoscopy vs laparotomy).MethodsA large general gynecologic ultrasonic database retrospectively identified 5218 patients for a 14-year period who presented to

APA, Harvard, Vancouver, ISO, and other styles

11

Arkfeld, Christopher, Julia Gelissen, Animesh Upadhyay, and Gary Altwerger. "Deep infiltrating endometriosis with mucinous metaplasia of mullerian origin." Journal of Endometriosis and Pelvic Pain Disorders 15, no. 2 (2023): 91–94. http://dx.doi.org/10.1177/22840265231178332.

Full text

Abstract:

Background: Endometriosis is a common gynecological condition that often presents with pelvic pain and infertility, but in rare cases may masquerade as a gastrointestinal or gynecologic malignancy. Case: A 49-year-old G0 presented with abdominal pain, fevers, elevated tumor markers, and a large adnexal mass concerning for malignancy. Intra-operatively, mucinous lesions diffusely involved abdominopelvic structures. Intra-operative frozen section (IOFS) revealed invasive cancer and full cytoreductive surgery was completed. Final pathology was downgraded to atypical cystic endometriosis with muci

APA, Harvard, Vancouver, ISO, and other styles

12

Ferdous, Jannatul, and Sabera Khatun. "Menopause and Gynecological Malignancy." Journal of SAFOMS 1, no. 2 (2013): 75–79. http://dx.doi.org/10.5005/jp-journals-10032-1017.

Full text

Abstract:

ABSTRACT Menopause is a consequence of biological aging. Menopause does not cause cancer, but the risk of developing cancer increase as a woman ages. Treatment of cancer can also cause premature menopause. Among the gynecological cancer, cervical cancer tops the list of common cancer. Postmenopausal women are prone to have persistent human papillomavirus (HPV) infection. There is no role of primary prevention of cervical cancer by vaccination in postmenopausal women. Secondary prevention by Paps smear only may provide false negative result as the cervix is often flushed with the vagina. So, sc

APA, Harvard, Vancouver, ISO, and other styles

13

Lashari, Bilal H., Megumi Asai, Gissele Randleman, Martha Sack, and Rajeshkumar Patel. "Sarcoid-Like Mediastinal Lymphadenopathy in Gynecologic Malignancy." Pulmonary Medicine 2018 (2018): 1–4. http://dx.doi.org/10.1155/2018/5141575.

Full text

Abstract:

Noncaseating granulomas are seen surrounding tumors with varying frequency, possibly as part of an immune response to tumor cells. However, data about the association of sarcoid with gynecologic malignancy is sparse. We performed a search of our institutional database for all EBUS-TBNA biopsies conducted within the past five years that revealed granulomatous inflammation. All adult female patients with a history of gynecologic malignancy were included. Patients with a history of sarcoidosis or fungal or mycobacterial infection were excluded. All patients with evidence of malignant cells on TBN

APA, Harvard, Vancouver, ISO, and other styles

14

Singh, Lilly, and Erin E. Stevens. "Leg Pain and Gynecologic Malignancy." American Journal of Hospice and Palliative Medicine® 30, no. 6 (2012): 594–600. http://dx.doi.org/10.1177/1049909112460422.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Nishio, Shin. "Antiangiogenic therapy in gynecologic malignancy." Annals of Oncology 27 (November 2016): vii18. http://dx.doi.org/10.1093/annonc/mdw465.004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Hyppolite, Jean-Claude, Indra D. Daniels, and Eli A. Friedman. "Obstructive Uropathy in Gynecologic Malignancy." ASAIO Journal 41, no. 3 (1995): M318—M323. http://dx.doi.org/10.1097/00002480-199507000-00022.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Zhang, ZY, and SZ Wang. "Laparoscopic surgery on gynecologic malignancy." Journal of the American Association of Gynecologic Laparoscopists 11, no. 3 (2004): S50—S51. http://dx.doi.org/10.1016/s1074-3804(04)80402-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Tierney, Christina, Helen E. Dinkelspiel, Anne R. Bass, Adela Cimic, Janine Katzen, and Kevin Holcomb. "Sclerosing mesenteritis mimics gynecologic malignancy." Gynecologic Oncology Reports 12 (April 2015): 49–51. http://dx.doi.org/10.1016/j.gore.2015.02.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Hayes, Katherine, and Amanda French. "Pediatric Gynecologic Malignancy and DICER1." Obstetrics & Gynecology 135 (May 2020): 90S. http://dx.doi.org/10.1097/01.aog.0000664076.39641.19.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Wong, Y. F., T. K. H. Chung, T. H. Cheung, et al. "p16INK4andp15INK4BAlterations in Primary Gynecologic Malignancy." Gynecologic Oncology 65, no. 2 (1997): 319–24. http://dx.doi.org/10.1006/gyno.1997.4669.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Larson, Matthew, Petra Lovrec, Elizabeth A. Sadowski, and Ali Pirasteh. "PET/MRI in Gynecologic Malignancy." Radiologic Clinics of North America 61, no. 4 (2023): 713–23. http://dx.doi.org/10.1016/j.rcl.2023.02.013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Larson, Matthew, Petra Lovrec, Elizabeth A. Sadowski, and Ali Pirasteh. "PET/MRI in Gynecologic Malignancy." PET Clinics 20, no. 3 (2025): 395–405. https://doi.org/10.1016/j.cpet.2025.04.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Yunokawa, Mayu. "New Treatment Options in Gynecologic Malignancy The PI3K/AKT/mTOR Inhibitor in Gynecologic Malignancy." Annals of Oncology 27 (November 2016): vii18. http://dx.doi.org/10.1093/annonc/mdw465.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Di Renzo, Maria Flavia, and Giorgio Valabrega. "Translational Research in Ovarian Cancer." Cancers 12, no. 12 (2020): 3676. http://dx.doi.org/10.3390/cancers12123676.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Hibner, M., J. F. Magrina, and P. M. Magtibay. "Free Floating Malignant Cells during Laparoscopy for Gynecologic Malignancy." Journal of Minimally Invasive Gynecology 15, no. 6 (2008): 42S. http://dx.doi.org/10.1016/j.jmig.2008.09.160.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Jaishuen, Atthapon, Camilo Jimenez, Nakarin Sirisabya, et al. "Poor Survival Outcome With Moderate and Severe Hypercalcemia in Gynecologic Malignancy Patients." International Journal of Gynecologic Cancer 19, no. 2 (2009): 178–85. http://dx.doi.org/10.1111/igc.0b013e31819c0fd0.

Full text

Abstract:

Objective:Determine the incidence of hypercalcemia in gynecologic malignancy patients and their survival outcome.Design:Single-institution retrospective clinical study.Patients and Methods:We used Fisher exact test, Kaplan-Meier survival curves, and Cox proportional hazards model to analyze demographic and clinical data from gynecologic malignancy patients with hypercalcemia who had been treated at The University of Texas M. D. Anderson Cancer Center from September 1997 to August 2006.Results:Of the 5260 gynecologic malignancy patients, 268 had hypercalcemia (5%). Of the 268, 12 were excluded

APA, Harvard, Vancouver, ISO, and other styles

27

Gabarin, Nadia, Emily Sirotich, Yang Liu, et al. "Perioperative Anemia Management in Women Undergoing Gynecologic Procedures: A 10 Year Multisite Study." Blood 138, Supplement 1 (2021): 752. http://dx.doi.org/10.1182/blood-2021-154182.

Full text

Abstract:

Abstract Background Preoperative anemia is a known risk factor for adverse patient outcomes. In women undergoing gynecologic surgery, preoperative anemia is independently associated with increased 30-day mortality, surgical complications, and hospital re-admission. Women with abnormal uterine bleeding and women undergoing gynecologic surgery remain under-studied and over-transfused. Patient blood management (PBM) initiatives are emerging from growing awareness of adverse outcomes associated with preoperative anemia. PBM efforts involve optimizing red cell mass and limiting unnecessary red bloo

APA, Harvard, Vancouver, ISO, and other styles

28

Matsuzaki, Shinya, Maximilian Klar, Erica J. Chang, et al. "Minimally Invasive Surgery and Surgical Volume-Specific Survival and Perioperative Outcome: Unmet Need for Evidence in Gynecologic Malignancy." Journal of Clinical Medicine 10, no. 20 (2021): 4787. http://dx.doi.org/10.3390/jcm10204787.

Full text

Abstract:

This study examined the effect of hospital surgical volume on oncologic outcomes in minimally invasive surgery (MIS) for gynecologic malignancies. The objectives were to assess survival outcomes related to hospital surgical volume and to evaluate perioperative outcomes and examine non-gynecologic malignancies. Literature available from the PubMed, Scopus, and the Cochrane Library databases were systematically reviewed. All surgical procedures including gynecologic surgery with hospital surgical volume information were eligible for analysis. Twenty-three studies met the inclusion criteria, and

APA, Harvard, Vancouver, ISO, and other styles

29

Pereira, Augusto, Javier F. Magrina, Paul M. Magtibay, Beatriz G. Stamps, Elena Muñoz-Nuñez, and Tirso Perez-Medina. "Granulomatosis with Polyangiitis-Mimicking Advanced Gynecological Cancer: A Case Report and Systematic Review of the Literature." Journal of Personalized Medicine 12, no. 2 (2022): 289. http://dx.doi.org/10.3390/jpm12020289.

Full text

Abstract:

(1) Background: Granulomatosis with polyangiitis (GPA) is a necrotizing vasculitis that mimics gynecologic cancer. In GPA patients, the genitourinary system is affected in <1%. The objective of the study was to provide a systematic review of the literature of GPA patients with gynecological involvement. (2) Methods: PubMed and Embase were searched from inception to July 2021 for GPA patients with gynecological involvement Medical Subject Headings (MeSH) and free-text terms. Exclusion criteria were other language, review articles, pregnancy, fertility, or male patients. Data were extracted o

APA, Harvard, Vancouver, ISO, and other styles

30

Jadav, Dr Sunil, and Dr Malini R. Desai. "Role of Percutaneous Nephrostomy in Obstructive Uropathy in Gynecologic Malignancy." International Journal of Scientific Research 3, no. 7 (2012): 428–29. http://dx.doi.org/10.15373/22778179/july2014/134.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Unal, Ece, Imran Khan, Olga Lavryk, et al. "IMPACT OF GYNECOLOGIC MALIGNANCY ON ILEAL POUCH-ANAL ANASTOMOSIS SURVIVAL: A MATCHED CASE-CONTROL STUDY." Inflammatory Bowel Diseases 31, Supplement_1 (2025): S21—S22. https://doi.org/10.1093/ibd/izae282.048.

Full text

Abstract:

Abstract BACKGROUND Total proctocolectomy with ileal pouch-anal anastomosis (IPAA) is the standard operative treatment for patients with medically refractory inflammatory bowel disease or familial adenomatous polyposis requiring colectomy. In patients who develop malignancy after IPAA, chemoradiation has been shown to increase the risk of pouch failure in small studies. We aimed to review our institutional experience with pouch survival after gynecologic surgery for malignancy, expecting that the presence of malignancy would be associated with higher rates of pouch failure. METHODS We retrospe

APA, Harvard, Vancouver, ISO, and other styles

32

Yadav, Budhi Singh, Suresh C. Sharma, Firuza D. Patel, Bhavana Rai, and Sushmita Ghoshal. "Gynecological Cancer as a Second Malignancy in Patients With Breast Cancer." International Journal of Gynecologic Cancer 27, no. 6 (2017): 1298–304. http://dx.doi.org/10.1097/igc.0000000000000993.

Full text

Abstract:

PurposeThe aim of this study was to determine the incidence and risk factors for gynecological cancer as second malignancy (SM) after treatment of breast cancer (BC).Methods and MaterialsBetween January 1985 and December 2007, a total of 2756 patients with BC were analyzed for gynecological cancers as an SM. Analysis was carried out for patient-, disease-, and treatment-related characteristics. The Cox proportional hazards regression model was used to estimate the relative risk of gynecologic malignancies.ResultsThe median age at BC diagnosis was 49 years and median follow-up of 14 years. In t

APA, Harvard, Vancouver, ISO, and other styles

33

Lai, Gillian, and Andrea G. Rockall. "Lymph Node Imaging in Gynecologic Malignancy." Seminars in Ultrasound, CT and MRI 31, no. 5 (2010): 363–76. http://dx.doi.org/10.1053/j.sult.2010.07.006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Grigsby, Perry W. "Role of PET in gynecologic malignancy." Current Opinion in Oncology 21, no. 5 (2009): 420–24. http://dx.doi.org/10.1097/cco.0b013e32832ec63f.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Jäger, Linda, Per J. Nilsson, and Angelique Flöter Rådestad. "Pelvic Exenteration for Recurrent Gynecologic Malignancy." International Journal of Gynecological Cancer 23, no. 4 (2013): 755–62. http://dx.doi.org/10.1097/igc.0b013e318287a874.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

FIORICA, J. "Atrial Natriuretic Factor in Gynecologic Malignancy." Obstetrics & Gynecology 85, no. 5 (1995): 740–44. http://dx.doi.org/10.1016/0029-7844(95)00036-q.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Tucker, Margaret A., and Joseph F. Fraumeni. "Treatment-related cancers after gynecologic malignancy." Cancer 60, S8 (1987): 2117–22. http://dx.doi.org/10.1002/1097-0142(19901015)60:8+<2117::aid-cncr2820601525>3.0.co;2-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Carter, J. R., J. M. Fowler, J. W. Carlson, L. F. Carson, L. L. Adcock, and L. B. Twiggs. "Prediction of malignancy using transvaginal color flow Doppler in patients with gynecologic tumors." International Journal of Gynecologic Cancer 3, no. 5 (1993): 279–84. http://dx.doi.org/10.1046/j.1525-1438.1993.03050279.x.

Full text

Abstract:

Eighty-five patients referred to the Women's Cancer Center, University of Minnesota had transvaginal color flow Doppler performed to determine if pelvic malignancy could be predicted by blood flow assessment. Their mean age was 49 years (range 21–86 years). Thirty-five patients were subsequently found to have malignant tumors of the cervix, uterus or ovary. The presence of increased intratumoral blood flow as depicted by color flow Doppler had a sensitivity of 83%, specificity of 100%, positive predictive value (PPV) of 100% and negative predictive value (NPV) of 89% for malignancy. The mean i

APA, Harvard, Vancouver, ISO, and other styles

39

Sherwani, Zohaib, Shreel Parikh, Nikhil Yegya-Raman, et al. "Stereotactic Body Radiation Therapy in Gynecologic Oligometastases: An Effective but Underutilized Approach." Cancers 15, no. 13 (2023): 3526. http://dx.doi.org/10.3390/cancers15133526.

Full text

Abstract:

Historically, the role of radiation in gynecological metastatic disease involved palliation for pain or bleeding. Stereotactic Body Radiation Therapy (SBRT) has shown survival benefits in oligometastatic disease from varying primary histologies in recent randomized trials. However, gynecologic primary oligometastases have been underrepresented in these trials. Recent studies across gynecological malignancy types have similarly shown favorable outcomes and acceptable toxicities from treating recurrent or oligometastatic gynecologic cancer (ROMGC) patients with definitive radiation therapy. The

APA, Harvard, Vancouver, ISO, and other styles

40

SANDRU, FLORICA, CLAUDIA MEHEDINȚU, AIDA PETCA, MIHAI CRISTIAN DUMITRASCU, ADELINA POPA, and ELIS CURTMOLA. "HPV Infection and Vulvar Cancer." Annals of the Academy of Romanian Scientists Series of Medicine 1, no. 1 (2020): 35–39. http://dx.doi.org/10.56082/annalsarscimed.2020.1.35.

Full text

Abstract:

Vulvar cancer is an uncommon gynecological malignancy primarily affecting postmenopausal women and is the fourth most common gynecologic cancer. There is no specific screening and the most effective strategy to reduce vulvar cancer incidence is the opportune treatment of predisposing and preneoplastic lesions associated with its development. Vulvar carcinoma can be HPV-positive or HPV- negative. Any suspicious vulvar lesion should be biopsied to exclude invasion.

APA, Harvard, Vancouver, ISO, and other styles

41

Yang, Eun-Jung, Ji-Hyeon Lee, A.-Jin Lee, et al. "Multiple Primary Malignancies in Patients with Gynecologic Cancer." Journal of Clinical Medicine 11, no. 1 (2021): 115. http://dx.doi.org/10.3390/jcm11010115.

Full text

Abstract:

Objective: To investigate the prevalence and oncologic outcomes of patients with multiple primary malignant tumors (MPMT) with gynecologic cancer. Methods: This retrospective study included 1929 patients diagnosed with gynecologic cancer at a tertiary medical center between August 2005 and April 2021. The clinical data included cancer location, age at primary malignancy diagnosis, interval between primary and secondary cancer, stage of cancer, family history of cancer, genetic testing, dates of last follow-up, recurrence, and death. Results: The prevalence of MPMT with gynecologic cancer in pa

APA, Harvard, Vancouver, ISO, and other styles

42

KINO, Nao, Masaki FUJIMURA, Takako SHIRAI, et al. "Fine needle aspiration cytology in gynecologic malignancy." Journal of the Japanese Society of Clinical Cytology 44, no. 1 (2005): 1–5. http://dx.doi.org/10.5795/jjscc.44.1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Kamura, Toshiharu, and Jin Dong Jeon. "Lymph Node Metastasis in a Gynecologic Malignancy." Yonsei Medical Journal 43, no. 6 (2002): 783. http://dx.doi.org/10.3349/ymj.2002.43.6.783.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Ghaith, S., G. K. Lewis, T. L. Burnett, M. N. Wasson, and A. R. Carrubba. "The Association of Endosalpingiosis with Gynecologic Malignancy." Journal of Minimally Invasive Gynecology 28, no. 11 (2021): S47. http://dx.doi.org/10.1016/j.jmig.2021.09.411.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

O'Donnell, Emily, Kalpana Devaraj, and Miriam D. Post. "Metastatic Hepatobiliary Cystadenocarcinoma Mimicking a Gynecologic Malignancy." AJSP: Reviews and Reports 27, no. 1 (2022): 2–4. http://dx.doi.org/10.1097/pcr.0000000000000460.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

BACKES, FLOOR J., and JEFFREY M. FOWLER. "Hysterectomy for the Treatment of Gynecologic Malignancy." Clinical Obstetrics and Gynecology 57, no. 1 (2014): 115–27. http://dx.doi.org/10.1097/grf.0000000000000006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Wong, Y. F., T. K. H. Chung, T. H. Cheung, et al. "Methylation of p16INK4A in primary gynecologic malignancy." Cancer Letters 136, no. 2 (1999): 231–35. http://dx.doi.org/10.1016/s0304-3835(98)00327-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Clark, Leslie H., and Kenneth H. Kim. "Tobacco Use and Outcomes in Gynecologic Malignancy." Current Obstetrics and Gynecology Reports 4, no. 4 (2015): 259–64. http://dx.doi.org/10.1007/s13669-015-0128-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Lai, Chyong-Huey, Tzu-Chen Yen, and Ting-Chang Chang. "Positron emission tomography imaging for gynecologic malignancy." Current Opinion in Obstetrics and Gynecology 19, no. 1 (2007): 37–41. http://dx.doi.org/10.1097/gco.0b013e32801195c9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Kudesia, Rashmi, and Divya Gupta. "Pelvic Salmonella Infection Masquerading as Gynecologic Malignancy." Obstetrics & Gynecology 118, no. 2, Part 2 (2011): 475–77. http://dx.doi.org/10.1097/aog.0b013e31821cfc8e.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!